Mark For: IMMUNOTAC® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88108651 |
Registration Number | 6707689 |
Mark Literal Elements | IMMUNOTAC |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-02-11 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Joi A. White |
Attorney Docket Number | T-4153/2 US |
Law Office Assigned | L90 |
Employee Name | STIGLITZ, SUSAN R |
2018-09-07 | Application Filed |
2018-12-19 | Status: Live/Pending |
2018-12-28 | Location: GENERIC WEB UPDATE |
2019-01-02 | Transaction Date |
2019-08-20 | Published |
2019-08-20 | Published for Opposition |
2020-02-11 | Location: INTENT TO USE SECTION |
2021-02-10 | Status: A second request for extension of time to file a Statement of Use has been granted. |
2022-04-19 | Trademark Registered |
Party: | Silverback Therapeutics, Inc. |
Address | 500 Fairview Avenue North, Suite 600 Seattle, WASHINGTON UNITED STATES 98109 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | IMAGE/JPEG | 2018-09-07 |
TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2018-09-07 |
XSearch Search Summary | XML | 2018-12-18 |
Offc Action Outgoing | XML | 2018-12-19 |
Administrative Response | XML | 2018-12-28 |
Administrative Response | XML | 2018-12-28 |
Response to Office Action | MULTI | 2019-06-18 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-06-20 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-07-09 |
Notice of Publication | XML | 2019-07-31 |
Notification Of Notice of Publication | XML | 2019-07-31 |
OG Publication Confirmation | XML | 2019-08-20 |
Notice of Allowance | XML | 2020-02-11 |
Extension of Time to File SOU | APPLICATION/XML | 2020-08-03 |
ITU Extension Approval | XML | 2020-08-05 |
ITU Unit Action | MULTI | 2020-08-05 |
Extension of Time to File SOU | XML | 2021-02-10 |
ITU Extension Approval | APPLICATION/XML | 2021-02-12 |
ITU Unit Action | MULTI | 2021-02-12 |
IC 042. US 100 101. G & S: Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates |
GS0421 | Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune modulatory conjugates; research and development of systemically delivered, locally active immune modulatory conjugates in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune modulatory conjugates in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune modulatory conjugates; pharmaceutical product development of systemically delivered, locally active immune modulatory conjugates |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-02-12 | |
TEAS EXTENSION RECEIVED | 2021-02-10 | |
EXTENSION 2 GRANTED | 2021-02-10 | 98765 |
EXTENSION 2 FILED | 2021-02-10 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-05 | |
TEAS EXTENSION RECEIVED | 2020-08-03 | |
EXTENSION 1 GRANTED | 2020-08-03 | 98765 |
EXTENSION 1 FILED | 2020-08-03 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-02-11 | |
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2019-12-29 | |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2019-09-18 | |
PUBLISHED FOR OPPOSITION | 2019-08-20 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-08-20 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-07-31 | |
ASSIGNED TO LIE | 2019-07-15 | 70633 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-07-08 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-19 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-06-18 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-18 | 88889 |
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | 2018-12-31 | 76487 |
LETTER OF PROTEST EVIDENCE FORWARDED | 2018-12-28 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-19 | 6325 |
NON-FINAL ACTION WRITTEN | 2018-12-19 | 76487 |
NON-FINAL ACTION E-MAILED | 2018-12-19 | 6325 |
ASSIGNED TO EXAMINER | 2018-12-18 | 76487 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-15 | |
NEW APPLICATION ENTERED IN TRAM | 2018-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.